Newron | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

2,201 results for “Newron”

Trials

View all 1985 →

OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism

112 participants · First posted Jun 28, 2013

Impairments of Neuro-muscular Communication in Motor-Neuron Disease: A Bio-Marker for Early and Personalised Diagnosis

400 participants · First posted Dec 23, 2022

Studying Motor Neuron Tests

47 participants · First posted Jan 25, 2012

Drugs

View all 47 →

SNN-0029

HF-1220

DCR-NEURO1

Organizations

View all 43 →

Newron Sweden AB

Sweden

NEWRON PHARMACEUTICALS SPA

Italy

NEWRON PHARMACEUTICALS S.P.A.

News

View all 126 →

Newron & Myung Collaborate for Evenamide Development in South Korea

Newron Pharmaceuticals Expands Evenamide Reach in Asia with New Licensing Agreements

Newron Pharmaceuticals Advances Pivotal Phase III Program for Treatment-Resistant Schizophrenia

Page 1 of 221